POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment

• Phase: Phase 4

Details

• Lead Sponsor: UCB Pharma
• Treatments: Cetirizine; Levocetirizine

Criteria

Inclusion Criteria:

• Clinical history of SAR known and treated since 2 years.

• Positive skin prick test (wheal > 3 mm larger than the diluent control) or RAST (≥3.5 IU/ml) to grass pollen (less than 1 year).

• Minimum mean T5SS of 8 during the baseline period.

Exclusion Criteria:

• Have an associated asthma requiring a daily treatment other than β2 short acting agonist prn

• Have atopic dermatitis or urticaria requiring antihistamine treatment or the administration of oral or topical corticosteroids and any other disease requiring the administration of oral or topical corticosteroids